Meds And Scans Interventions Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-07-2024
- Paid Up Capital ₹ 4.60 M
as on 17-07-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 17-07-2024
- Revenue 131.18%
(FY 2022)
- Profit -81.99%
(FY 2022)
- Ebitda -34.69%
(FY 2022)
- Net Worth 2.07%
(FY 2022)
- Total Assets 35.83%
(FY 2022)
About Meds And Scans Interventions
The Corporate was formerly known as Deeva Cars Private Limited. The Company is engaged in the Automotive Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.60 M.
The company currently has active open charges totaling ₹2.00 Cr.
Virendra Singh and Prashant Sharma serve as directors at the Company.
- CIN/LLPIN
U50400MP2016PTC040884
- Company No.
040884
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Meds And Scans Interventions?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Virendra Singh  | Director | 03-Jun-2016 | Current |
| Prashant Sharma | Additional Director | 01-May-2021 | Current |
Financial Performance of Meds And Scans Interventions.
Meds And Scans Interventions Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 131.18% increase. The company also saw a substantial fall in profitability, with a 81.99% decrease in profit. The company's net worth moved up by a moderate rise of 2.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meds And Scans Interventions?
In 2021, Meds And Scans Interventions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 02 Jun 2021 | ₹2.00 Cr | Open |
How Many Employees Work at Meds And Scans Interventions?
Unlock and access historical data on people associated with Meds And Scans Interventions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meds And Scans Interventions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meds And Scans Interventions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
